Recent nanotechnology research has been enhancing or creating new applications that have the potential to advance the diagnosis or therapy of diseases. These contributions to the field of nanomedicine have so far been focused on creating the new technologies rather than focusing on particular diseases in order to improve their outcomes. For the latter to occur, we recommend the following: (1) creation of interdisciplinary research funding that awards collaborations between biological, medical, clinical, and pharmaceutical scientists with their colleagues in engineering, physics, and chemistry, (2) increasing the training of bio-and medical students in the field of nanotechnology, and (3) focusing on specific diseases for creating nano-based solutions. In this review, we focus on ovarian cancer as an example of a disease that could benefit from advances in nanotechnology to enhance its understanding, diagnosis, and therapy. We also stress the need to train biological, medical, clinical, and pharmaceutical students in the field of nanotechnology with presenting results on such training in USA pharmacy schools.

No abstract